High rate of reinfection with the SARS-CoV-2 Omicron variant
- PMID: 35472367
- PMCID: PMC9033627
- DOI: 10.1016/j.jinf.2022.04.034
High rate of reinfection with the SARS-CoV-2 Omicron variant
Conflict of interest statement
Declaration of interest The authors have no conflicts of interest to declare relative to the present study. Didier Raoult was a consultant for the Hitachi High-Technologies Corporation, Tokyo, Japan from 2018 to 2020. He is a scientific board member of the Eurofins company and a founder of a microbial culture company (Culture Top). Funding sources had no role in the design and con-duct of the study, the collection, management, analysis, and interpretation of the data, and the preparation, review, or approval of the manuscript.
Figures
Comment in
-
"Rapid reinfections with different or same Omicron SARS-CoV-2 sub-variants".J Infect. 2022 Oct;85(4):e96-e98. doi: 10.1016/j.jinf.2022.07.003. Epub 2022 Jul 8. J Infect. 2022. PMID: 35810939 Free PMC article. No abstract available.
Comment on
-
Antibody titers and breakthrough infections with Omicron SARS-CoV-2.J Infect. 2022 Apr;84(4):e13-e15. doi: 10.1016/j.jinf.2022.01.044. Epub 2022 Feb 3. J Infect. 2022. PMID: 35123960 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
